Detailed studies on regulatory mechanisms of production and secretion of total and active ghrelin levels in cancer patients at risk of developing cachexia are needed to evaluate the potential of ghrelin as a biomarker for cachexia. This evidence concerns the gene GHRL and Cachexia.